Research Data for “Spesolimab in the FDA Adverse Event Reporting System: A Disproportionality Analysis”
Published: 25 August 2026| Version 1 | DOI: 10.17632/r6mr33vgtz.1
Contributors:
AHMET UĞUR ATILAN, Niyazi ÇetinDescription
This dataset contains research data from a disproportionality analysis of spesolimab-associated adverse events using the FDA Adverse Event Reporting System (FAERS). The dataset includes analytical datasets, signal detection results, comparator analyses, and supporting safety assessments derived from FAERS reports.
Files
Institutions
- Pamukkale UniversityDenizli, Denizli
Categories
Drug Safety, Pharmacovigilance, Disproportionality Analysis